VRTXVertex PharmaceuticalsHealth Care
$541.69EarningsNov 2, 2026
1D—1W—1M—3M—1Y—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +38.9% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E32.1×3446
22
32
P / S11.3×811
7
12
P / FCF37.4×2020
19
36
EV / EBITDA25.4×1824
14
248
P / E (fwd)28.9×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin86.3%9692
86%
88%
Operating margin39.0%9295
-7%
49%
Net margin35.4%9499
-9%
39%
ROE24.4%7480
-6%
31%
ROIC20.7%8583
-4%
28%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.009794
0.0
0.1
Net debt / EBITDA-1.4×8881
Current ratio3.028474
Interest coverage463.7×9189
Per shareTTM, with year-over-year change
Revenue / share$47.82▲ +10%
EPS (diluted)$16.86▲ +530%
FCF / share$14.48▲ +395%
Est. EPS growth (fwd)+14%